Sectors
SUPN
Supernus Pharmaceuticals, Inc.
47.70
1 x 47.46
2 x 47.63
bid
ask
-
0.17
0.36%
10:03 AM
timesize
| Ytd | -4.02% | |
| 1y | 46.01% |
47.50
day range
48.13
32.51
52 week range
59.68
| Open | 47.87 | Prev Close | 47.87 | Low | 47.50 | High | 48.13 | Mkt Cap | 2.78B |
| Vol | 13.86K | Avg Vol | 773.64K | EPS | 3.43 | P/E | 13.96 | Forward P/E | 20.16 |
| Beta | 0.54 | Short Ratio | 8.79 | Inst. Own | 102.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 46.93 | 200-d Avg | 49.10 | 1yr Est | 63.50 |
| Income Statement | |||
| Total Revenue | 207.71M | ||
| Revenues (USD) | 207.71M | ||
| Cost of Revenue | 23.39M | ||
| Gross Profit | 184.31M | ||
| Operating Expenses | 190.26M | ||
| Research and Development Expense | 39.44M | ||
| Selling, General and Administrative Expense | 125.17M | ||
| Operating Income | -5.94M | ||
| Income Tax Expense | -3.66M | ||
| Net Income | -2.29M | ||
| Net Income Common Stock | -2.29M | ||
| Net Income Common Stock (USD) | -2.29M | ||
| Consolidated Income | -2.29M | ||
| Earnings per Basic Share | -0.04 | ||
| Earnings per Basic Share (USD) | -0.04 | ||
| Earnings per Diluted Share | -0.04 | ||
| Earning Before Interest & Taxes (EBIT) | -5.95M | ||
| Earning Before Interest & Taxes (USD) | -5.95M | ||
| Weighted Average Shares | 57.65M | ||
| Weighted Average Shares Diluted | 57.65M | ||
| Balance Sheet | |||
| Cash and Equivalents | 186.32M | ||
| Cash and Equivalents (USD) | 186.32M | ||
| Investments | 199.37M | ||
| Investments Current | 199.37M | ||
| Trade and Non-Trade Receivables | 182.18M | ||
| Current Assets | 731.58M | ||
| Property, Plant & Equipment Net | 10.04M | ||
| Total Assets | 1.50B | ||
| Total Debt | 30.27M | ||
| Current Liabilities | 373.93M | ||
| Debt Non-Current | 30.27M | ||
| Total Liabilities | 423.92M | ||
| Accumulated Retained Earnings (Deficit) | 515.58M | ||
| Accumulated Other Comprehensive Income | -255.00K | ||
| Shareholders Equity | 1.08B | ||
| Shareholders Equity (USD) | 1.08B | ||
| Assets Non-Current | 769.15M | ||
| Total Debt (USD) | 30.27M | ||
| Goodwill and Intangible Assets | 670.38M | ||
| Inventory | 87.06M | ||
| Liabilities Non-Current | 49.99M | ||
| Trade and Non-Trade Payables | 101.24M | ||
| Tax Assets | 30.82M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 28.39M | ||
| Net Cash Flow from Financing | 9.12M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 56.42M | ||
| Issuance (Purchase) of Equity Shares | 13.67M | ||
| Net Cash Flow from Investing | -19.22M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -19.22M | ||
| Net Cash Flow from Operations | 66.52M | ||
| Share Based Compensation | 8.48M | ||